miR-539 acts as a tumor suppressor by targeting epidermal growth factor receptor in breast cancer

[1]  G. Kristiansen,et al.  Hypoxia-inducible factor prolyl hydroxylase 2 (PHD2) is a direct regulator of epidermal growth factor receptor (EGFR) signaling in breast cancer , 2016, Oncotarget.

[2]  Y. Miao,et al.  MicroRNA‐106b targets FUT6 to promote cell migration, invasion, and proliferation in human breast cancer , 2016, IUBMB life.

[3]  Yan Cheng,et al.  MiRNA-183-5p promotes cell proliferation and inhibits apoptosis in human breast cancer by targeting the PDCD4. , 2016, Reproductive biology.

[4]  Yeqing Huang,et al.  hsa-miR-135a-1 inhibits prostate cancer cell growth and migration by targeting EGFR , 2016, Tumor Biology.

[5]  Jiayuan Li,et al.  MiR-4653-3p and its target gene FRS2 are prognostic biomarkers for hormone receptor positive breast cancer patients receiving tamoxifen as adjuvant endocrine therapy , 2016, Oncotarget.

[6]  Hong Zhao,et al.  miR-145 suppresses breast cancer cell migration by targeting FSCN-1 and inhibiting epithelial-mesenchymal transition. , 2016, American journal of translational research.

[7]  G. Kibria,et al.  miR-206 Inhibits Stemness and Metastasis of Breast Cancer by Targeting MKL1/IL11 Pathway , 2016, Clinical Cancer Research.

[8]  Yong Xu,et al.  miR-539 inhibits prostate cancer progression by directly targeting SPAG5 , 2016, Journal of Experimental & Clinical Cancer Research.

[9]  Xiao-Fan Wang,et al.  MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer , 2016, Oncotarget.

[10]  L. Lv,et al.  miR‐539 induces cell cycle arrest in nasopharyngeal carcinoma by targeting cyclin‐dependent kinase 4 , 2015, Cell biochemistry and function.

[11]  Weiming Sun,et al.  MiR-539 inhibits thyroid cancer cell migration and invasion by directly targeting CARMA1. , 2015, Biochemical and biophysical research communications.

[12]  Liang-liang Dong,et al.  Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer , 2015, Diagnostic Pathology.

[13]  L. Sempere,et al.  Critical analysis of the potential for microRNA biomarkers in breast cancer management , 2015, Breast cancer.

[14]  M. Matboli,et al.  MicroRNA-10b and minichromosome maintenance complex component 5 gene as prognostic biomarkers in breast cancer , 2015, Tumor Biology.

[15]  A. Jemal,et al.  Cancer treatment and survivorship statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[16]  Minghui Zhang,et al.  Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients , 2014, Targeted Oncology.

[17]  Eva E. Rufino-Palomares,et al.  MicroRNAs as Oncogenes and Tumor Suppressors , 2013 .

[18]  M. Tania,et al.  MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects , 2013, Tumor Biology.

[19]  R. Schiff,et al.  Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes , 2010, Cancer.

[20]  S. Shenouda,et al.  MicroRNA function in cancer: oncogene or a tumor suppressor? , 2009, Cancer and Metastasis Reviews.

[21]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[22]  M. Marie.  Diagnostic and therapeutic aspects , 2009 .

[23]  Sun Mi Park,et al.  MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death , 2008, Oncogene.

[24]  Thomas D. Schmittgen,et al.  Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.

[25]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[26]  V. Bossuyt,et al.  Remarkably High Frequency of EGFR Expression in Breast Carcinomas with Squamous Differentiation , 2005, International journal of surgical pathology.

[27]  J. Mendell.  MicroRNAs: Critical Regulators of Development, Cellular Physiology and Malignancy , 2005, Cell cycle.

[28]  Lin He,et al.  MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature Reviews Genetics.

[29]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[30]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.